Skip to main content
. 2016 Mar 7;2016(3):CD009541. doi: 10.1002/14651858.CD009541.pub2

NCT02234830.

Trial name or title CLOSE‐UP II trial
Methods Study design : randomised parallel‐assignment open‐label
Country : Denmark
Setting : hospital
Number of centres : multi‐centre
Participants Inclusion criteria
  • Ability to provide valid informed signed consent

  • PCI procedure including treatment by balloon and/or stent

  • PCI indicated by silent ischaemia, stable angina pectoris, non‐ST elevation myocardial infarction (NSTEMI) or ST elevation myocardial infarction (STEMI)


Exclusion criteria
  • Only coronary angiography

  • Multiple punctures

  • Active infection

  • Groin haematoma before the closure procedure

  • Sheath size > 7 Fr

  • Known pseudoaneurysm or arterio‐venous (AV) fistula in the ipsilateral groin

  • Prior arterial surgery in abdomen and/or lower extremities

  • Cardiogenic shock

  • Life expectancy < 1 year

  • Female of childbearing potential with possible pregnancy or positive pregnancy test within 7 days before index procedure, or lactating

  • Simultaneous or planned subsequent femoral vein access

  • Allergy to any of the components in the closure material left in the groin

  • Puncture of same site < 30 days

  • Peripheral artery disease patients can be included at operator's discretion except if heavy calcification is present at the access site, which at the operator's discretion precludes insertion of the VCD

Interventions Intervention 1 : AngioSeal
Intervention 2 : ExoSeal
Outcomes Primary
  • Incidence at 30 days of the composite endpoint of access site‐related major adverse vascular events. This includes major bleeding and/or bleeding necessitating blood transfusion, pseudoaneurysm with indication for treatment, arteriovenous fistula, groin surgery and/or possible related vascular surgery and infection needing antibiotic


Secondary
  • Time to haemostasis from removal of the sheath (AngioSeal) or insertion of the device (ExoSeal) until haemostasis

  • Device failure

  • Vasovagal reaction until 5 minutes after end of closure procedure

  • Need for new onset of manual compression

  • Pain and discomfort related to the closure procedure

  • Time to mobilisation

  • In‐hospital large groin haematoma

  • Bleeding according to BARC definitions

  • Major bleeding and/or bleeding necessitating blood transfusion

  • Pseudoaneurysm with indication for treatment

  • Arteriovenous fistula

  • Groin surgery and/or possible related vascular surgery

  • Infection needing antibiotics

  • Need for medical evaluation of possible closure procedure‐related symptom(s)

Starting date December 2012
Contact information hellbarg@rm.dk
niels.holm@clin.au.dk
Notes